羚鋭製藥(600285.SH)大股東羚鋭集團質押1000萬股
格隆匯4月30日丨羚鋭製藥(600285.SH)發佈,公司於2020年4月30日接到大股東羚鋭集團關於部分股份質押的通知,羚鋭集團將所持有的公司無限售流通股1000萬股質押給平頂山銀行股份有限公司信陽分行。
羚鋭集團持有公司股票1.22億股,佔公司總股本比例為21.45%。本次質押後,羚鋭集團持有公司股份累計質押數量8591.05萬股,佔其持股數量比例為70.52%,佔公司總股本的15.13%。
截至本公告日,羚鋭集團一致行動人信陽新鋭投資發展有限公司、新縣鑫源貿易有限公司所持公司股份質押數量分別為960萬股、753.83萬股,一致行動人熊維政、熊偉未質押公司股份。羚鋭集團及其一致行動人累計質押公司股份1.03億股,佔羚鋭集團及其一致行動人合計所持公司股份的69.31%,佔公司總股本的18.15%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.